GSK3A and cancer: We have shown that 2 inhibits mitochondrial complex V and induces mitochondrial dysfunction like oligomycin A. ROS production by the damaged mitochondria activated GSK3α/β, phosphorylating c-Myc for ubiquitin-dependent degradation, which is responsible for the growth inhibition of cancer cells (Fig. 6).